Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review

References

• Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Special topic: hPV-associated cancers. ( Members of the Canadian Cancer Statistics Advisory Committee, ed); 2016.
   Google Scholar
• D’souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263–27. doi:10.1086/597755.
   PubMed Web of Science ®Google Scholar
• Dubé E, Gagnon D, Clément P, Bettinger JA, Comeau JL, Deeks S, Guay M, MacDonald S, MacDonald NE, Mijovic H, et al. Challenges and opportunities of school-based HPV vaccination in Canada. Hum Vaccines Immunother. 2019;15(7–8):1650–55. doi:10.1080/21645515.2018.1564440.
   PubMed Web of Science ®Google Scholar
• The Canadian Cancer Society. Statistics Canada and the Public Health Agency of Canada, in collaboration with the provincial and territorial cancer registries. A 2022 special report on cancer prevalence; 2022. http://cancer.ca/Canadian-Cancer-Statistics-2022-EN.
   Google Scholar
• Canadian Institute for Health Information. Wait times for priority procedures in Canada, 2021: focus on the first 6 months of the COVID-19 pandemic. Published online 2021. https://www.cihi.ca/sites/default/files/document/wait-times-chartbook-priority-procedures-in-canada-2016-2020-en.pdf.
   Google Scholar
• Smith A, Baines N, Memon S, Fitzgerald N, Chadder J, Politis C, Nicholson E, Earle C, Bryant H. Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines. Curr Oncol. 2019;26(2):80–84. doi:10.3747/co.26.4795.
   PubMed Web of Science ®Google Scholar
• Cervical cancer. [Accessed 2022 Dec 1]. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
   Google Scholar
• CDC. About HPV. Published 2020 Mar 19 [accessed 2020 Oct 7]. https://www.cdc.gov/hpv/parents/about-hpv.html.
   Google Scholar
• Lee S Human papillomavirus. Canadian Cancer Society. [Accessed 2022 Dec 1]. https://cancer.ca/en/cancer-information/reduce-your-risk/get-vaccinated/human-papillomavirus-hpv.
   Google Scholar
• Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000res. 2017;6:866. doi:10.12688/f1000research.10691.1.
   PubMedGoogle Scholar
• Canadian Cancer Statistics. Special topics: cancer in adolescents and young adults. ( Loraine Marrett, Prithwish De, Dagny Dryer, Larry Ellison, Eva Grunfeld, Heather Logan, Maureen Maclntyre, Les Mer, Howard Morrison. The Canadian Cancer Society’s Steering Committee for Canadian Cancer Statistics., ed); 2009.
   Google Scholar
• Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Special Topic: HPV-Associated Cancers. ( Canadian Cancer Statistics., ed). Toronto (ON): Canadian Cancer Society; Canadian Cancer Statistics; 2016.
   Google Scholar
• McDonald JT, Kennedy S. Cervical cancer screening by immigrant and minority women in Canada. J Immigrant Min Health. 2007;9(4):323–34. doi:10.1007/s10903-007-9046-x.
   PubMedGoogle Scholar
• Engel GL. The clinical application of the biopsychosocial model. J Med Philos. 1981;6(2):101–23. doi:10.1093/jmp/6.2.101.
   PubMed Web of Science ®Google Scholar
• Israel S. How social policies can improve financial accessibility of healthcare: a multi-level analysis of unmet medical need in European countries. Int J Equity Health. 2016;15(1):41. doi:10.1186/s12939-016-0335-7.
   PubMedGoogle Scholar
• Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12(1):18. doi:10.1186/1475-9276-12-18.
   PubMed Web of Science ®Google Scholar
• Beshears J, Choi JJ, Laibson DI, Madrian BC, Reynolds GI. Vaccination rates are associated with functional proximity but not base proximity of vaccination clinics. Med Care. 2016;54(6):578–83. doi:10.1097/MLR.0000000000000523.
   PubMed Web of Science ®Google Scholar
• Crawshaw AF, Farah Y, Deal A, Rustage K, Hayward SE, Carter J, Knights F, Goldsmith LP, Campos-Matos I, Wurie F, et al. Defining the determinants of vaccine uptake and under vaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis. 2022;22(9):e254–66. doi:10.1016/S1473-3099(22)00066-4.
   PubMed Web of Science ®Google Scholar
• Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health J. 2021;5(1):51–55. doi:10.1016/j.glohj.2021.02.005.
   PubMedGoogle Scholar
• Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos‐achirica M, Nasir K. Determinants of influenza vaccine uptake in patients with cardiovascular disease and strategies for improvement. J Am Heart Assoc. 2021;10(15):e019671. doi:10.1161/JAHA.120.019671.
   PubMed Web of Science ®Google Scholar
• Bibliothèque/Library. Guides de recherche research guides: systematic reviews: planning. Published online 2017 Jul 31 [accessed 2021 Apr 21]. https://uottawa.libguides.com/systematicreview/planning
   Google Scholar
• Luo A Content Analysis. Published 2019 Jul 18 [accessed 2021 Apr 21]. https://www.scribbr.com/methodology/content-analysis/
   Google Scholar
• Regional Health Authority. NB. Reasons for no or under HPV immunization-report_school-year_2015-2016- Newbrunscwick-Nb.Pdf. 2016.
   Google Scholar
• Regional Health Authority. NB. Reasons for no or under HPV immunization-report_school-year_2017-2018-Newbrunscwick-Nb.Pdf. 2017.
   Google Scholar
• Regional Health Authority. NB. Reasons for no or under HPV immunization-report_school-year_2018-2019-Newbrunscwick-Nb.Pdf. 2019.
   Google Scholar
• HPV ad hoc scientific committee. HPV vaccination in Québec: knoweledge update and expert panel proposals.Pdf. Published online 2012.
   Google Scholar
• Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14(1):700. doi:10.1186/1471-2458-14-700.
   PubMedGoogle Scholar
• Grace D, Gaspar M, Rosenes R, Grewal R, Burchell AN, Grennan T, Salit IE. Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians’ challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men. Int J Equity Health. 2019;18(1). doi:10.1186/s12939-019-1067-2.
   Web of Science ®Google Scholar
• Grace D, Gaspar M, Paquette R, Rosenes R, Burchell AN, Grennan T, Salit IE. HIV-positive gay men’s knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: a qualitative study. PLoS One. 2018;13(11):e0207953. doi:10.1371/journal.pone.0207953.
   PubMed Web of Science ®Google Scholar
• Scott K, Batty ML. HPV vaccine uptake among Canadian youth and the role of the nurse practitioner. J Community Health. 2016;41(1):197–205. doi:10.1007/s10900-015-0069-2.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JML. Human papillomavirus vaccine introduction – the first five years. Vaccine. 2012;30:F139–48. doi:10.1016/j.vaccine.2012.05.039.
   PubMed Web of Science ®Google Scholar
• Wilson SE, Karas E, Crowcroft NS, Bontovics E, Deeks SL. Ontario’s school-based HPV immunization program: school board assent and parental consent. Can J Public Health. 2012;103(1):34–39. doi:10.1007/BF03404066.
   PubMed Web of Science ®Google Scholar
• Isenor JE, Slayter KL, Halperin DM, McNeil SA, Bowles SK. Pharmacists’ immunization experiences, beliefs, and attitudes in New Brunswick, Canada. Pharm Pract (Granada). 2018;16(4):1310. doi:10.18549/pharmpract.2018.04.1310.
   PubMed Web of Science ®Google Scholar
• Henderson RI, Shea-Budgell M, Healy C, Letendre A, Bill L, Healy B, Bednarczyk RA, Mrklas K, Barnabe C, Guichon J, et al. First nations people’s perspectives on barriers and supports for enhancing HPV vaccination: foundations for sustainable, community-driven strategies. Gynecol Oncol. 2018;149(1):93–100. doi:10.1016/j.ygyno.2017.12.024.
   PubMed Web of Science ®Google Scholar
• Fernandes R, Potter BK, Little J. Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada. BMC Womens Health. 2018;18(1):134. doi:10.1186/s12905-018-0622-0.
   PubMedGoogle Scholar
• Rubens-Augustson T, Wilson LA, Murphy MS, Jardine C, Pottie K, Hui C, Stafström M, Wilson K. Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study. Hum Vaccin Immunother. 2019;15(7–8):1697–707. doi:10.1080/21645515.2018.1539604.
   PubMed Web of Science ®Google Scholar
• Bird Y, Obidiya O, Mahmood R, Nwankwo C, Moraros J. Human papillomavirus vaccination uptake in Canada: a systematic review and meta-analysis. Int J Prev Med. 2017;8(1):71. doi:10.4103/ijpvm.IJPVM_49_17.
   PubMedGoogle Scholar
• Shapiro GK, Guichon J, Kelaher M. Canadian school-based HPV vaccine programs and policy considerations. Vaccine. 2017;35(42):5700–07. doi:10.1016/j.vaccine.2017.07.079.
   PubMed Web of Science ®Google Scholar
• Mrklas KJ, MacDonald S, Shea-Budgell MA, Bedingfield N, Ganshorn H, Glaze S, Bill L, Healy B, Healy C, Guichon J, et al. Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian indigenous peoples: a systematic review protocol. Syst Rev. 2018;7(1):40. doi:10.1186/s13643-018-0692-y.
   PubMedGoogle Scholar
• Janeczek O Region of peel – public health. Improving Human Papilloma Virus (HPV) vaccine uptake: a rapid review. Published online 2019.
   Google Scholar
• Canadian Immunization Committee. Recommendations for HPV immunization programs-Canadian immunization committee-SK.Pdf. Published online 2014.
   Google Scholar
• Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7(5):e1000270. doi:10.1371/journal.pmed.1000270.
   PubMed Web of Science ®Google Scholar
• Stanley C, Secter M, Chauvin S, Selk A. HPV vaccination in male physicians: a survey of gynecologists and otolaryngology surgeons’ attitudes towards vaccination in themselves and their patients. Papillomavirus Res. 2018;5:89–95. doi:10.1016/j.pvr.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Remes O, Smith LM, Alvarado-Llano BE, Colley L, Lévesque LE. Individual- and regional-level determinants of human papillomavirus (HPV) vaccine refusal: the Ontario grade 8 HPV vaccine cohort study. BMC Public Health. 2014;14(1):1047. doi:10.1186/1471-2458-14-1047.
   PubMed Web of Science ®Google Scholar
• McComb E, Ramsden V, Olatunbosun O, Williams-Roberts H. Knowledge, attitudes and barriers to Human Papillomavirus (HPV) vaccine uptake among an immigrant and refugee catch-up group in a Western Canadian province. J Immigr Minor Health. 2018;20(6):1424–28. doi:10.1007/s10903-018-0709-6.
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Perez S, King L, Vivion M, Dubé E, Rosberger Z. Parents’ decision-making about the human papillomavirus vaccine for their daughters: iI. Qualitative results. Hum Vaccines Immunother. 2015;11(2):330–36. doi:10.4161/21645515.2014.980708.
   PubMed Web of Science ®Google Scholar
• Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med. 2014;58:22–32. doi:10.1016/j.ypmed.2013.10.009.
   PubMed Web of Science ®Google Scholar
• Carpiano RM, Polonijo AN, Gilbert N, Cantin L, Dubé E. Socioeconomic status differences in parental immunization attitudes and child immunization in Canada: findings from the 2013 Childhood National Immunization Coverage Survey (CNICS). Prev Med. 2019;123:278–87. doi:10.1016/j.ypmed.2019.03.033.
   PubMed Web of Science ®Google Scholar
• Musto R, Siever JE, Johnston JC, Seidel J, Rose MS, McNeil DA. Social equity in human papillomavirus vaccination: a natural experiment in Calgary Canada. BMC Public Health. 2013;13(1):640. doi:10.1186/1471-2458-13-640.
   PubMed Web of Science ®Google Scholar
• Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–67. doi:10.1016/j.vaccine.2017.12.043.
   PubMed Web of Science ®Google Scholar
• Dubé E, Gilca V, Sauvageau C, Bettinger JA, Boucher FD, McNeil S, Gemmill I, Lavoie F, Ouakki M, Boulianne N. Clinicians’ opinions on new vaccination programs implementation. Vaccine. 2012;30(31):4632–37. doi:10.1016/j.vaccine.2012.04.100.
   PubMed Web of Science ®Google Scholar
• Whelan NW, Steenbeek A, Martin-Misener R, Scott J, Smith B, D’angelo-Scott H. Engaging parents and schools improves uptake of the human papillomavirus (HPV) vaccine: examining the role of the public health nurse. Vaccine. 2014;32(36):4665–71. doi:10.1016/j.vaccine.2014.06.026.
   PubMed Web of Science ®Google Scholar
• McLeod SA Attitudes and behavior. Published online 2018 [accessed 2019 Jan 21].
   Google Scholar
• Dube E Prevention by vaccination of diseases attributable to HPV-QUBEC.Pdf. Published online 2008.
   Google Scholar
• Cascini F, Pantovic A, Al-Ajlouni YA, Failla G, Puleo V, Melnyk A, Lontano A, Ricciardi W. Social media and attitudes towards a COVID-19 vaccination: a systematic review of the literature. EClinicalMedicine. 2022;48:101454. doi:10.1016/j.eclinm.2022.101454.
   PubMedGoogle Scholar
• Tsao SF, Chen H, Tisseverasinghe T, Yang Y, Li L, Butt ZA. What social media told us in the time of COVID-19: a scoping review. Lancet Digit Health. 2021;3(3):e175–94. doi:10.1016/S2589-7500(20)30315-0.
   PubMedGoogle Scholar
• WHO. Draft: global strategy towards eliminating cervical cancer as a public health problem. Geneva, Switzerland. Published online 2019.
   Google Scholar